Study of prevalence of insulin resistance in non-diabetes hypertensive patients attending medicine OPD at a tertiary care center

 

K V Giriraja¹, Madhusudan C^2*

 

 

REFERENCES

1. Schulman IH, Zhou MS: Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases. CurrHypertens Rep. 2009, 11: 48-55.
2. Soeters MR, Soeters PB, Schooneman MG, Houten SM, Romijn JA: Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation. Am J PhysiolEndocrinolMetab. 2012, 303: E1397-E1407
3. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Global burden of hypertension: analysis of world-wide data. Lancet 2005; 365(9455): 217-23.
4. Boon NA, Colledge NR, Walker BR, Hunter JAA. Davidson’s Principles and Practice of Medicine. 20th ed. India: Elsevier Limited; 2006.
5. 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults J Am CollCardiol. Sep 2017, 23976; DOI: 10.1016/j.jacc.2017.07.745 cited on (Sept 2018) available from https://www.acc.org/~/media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Guidelines/2017/Guidelines_Made_Simple_2017_HBP.pdf
6. Gupta R. Trends in hypertension epidemiology of hypertension in India. J hum hypertens. 2004;18:73-8
7. Wolf-Maier K, Cooper RS, Banegas JR, Giampolis S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003; 289:2363–9. [PubMed]
8. Meigs JB, D’Agostino RB, Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE, et al. Risk variable clustering in the insulin resistance syndrome.The Framingham Offspring Study.Diabetes. 1997; 46:1594–600. [PubMed]
9. Working Group Report on Primary Prevention of Hypertension: National High Blood Pressure Education Program, Bethesda, Md: National Institutes of Health. National Institutes of Health, National Heart, Lung and Blood Institute document number 93-2669. 1993
10. Kannel WB. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens. 2000; 13:S3–10. [PubMed]
11. Defrenzo RA. Insulin and renal sodium handling; clinical implication.Int J Obes. 1981;5(2):93-105.
12. Rowe JW, Young JB, Minaker KL.Effect of insulin and glucose infusion on symapatthetic nervous system activity in normal man.Diabetes. 1981; 30:219-25.
13. Reaven GM. Banting Lecture 1988.Role of insulin resistance in human disease.Diabetes.1988; 37:1595–607.
14. Executive summary: The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001; 285:2486–97.
15. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol. 1982; 243:15-30.
16. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose tolerance. J Clin Invest. 1985; 75:809-17.
17. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall AE, et al. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia. 1987; 30:719-23.
18. Manicardi V, Cannellini I, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J ClinEndocrinolMetab. 1986; 62:1302-4.
19. International Diabetes Federation. The IDF consensus worldwide de­finition of the METABOLIC SYNDROME cited on sept 2018. Available from https://www.idf.org/component/attachments/attachments.html?id=705andtask=download
20. Judzewitch RG. Drug insulin enzyme immunoassay kit: chronic chlorpropamide therapy of non-insulin dependent diabetes augments basal and stimulated insulin secretions by increasing islet sensitivity to glucose. J Clin End Metab. 2005;55(2):321-8
21. Ferrannini E, Mari A. How to measure insulin sensitivity.J Hypertension. 1998; 16:895-906.
22. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocrine Journal. 2001; 48:81-6.
23. Bonoram E, Targher G, Alberiche M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000; 23:57-63.
24. Salvetti A, Brogi G, Di Legge V, Bernini GP. The inter-relationship between insulin resistance and hypertension. Drugs. 1993; 46Suppl 2:149-59. Review. PubMed PMID: 7512468.
25. Gupta AK, Jain SK. A study to evaluate surrogate markers of insulin resistance in forty euglycaemic healthy subjects.J Assoc Physicians India. 2004; 5:549-53.
26. Sinha S, Akhter QS, Banik S, Zakirul MI, Haque M. Correlation Study of Insulin Resistance and Essential Hypertension among Bangladeshi Male Volunteers Journal of Young Pharmacists Vol 7 ● Issue 3 ● Jul-Sep 2015 Pp 200-205
27. Misra A, Vikram KN. Insulin resistance syndrome (metabolic syndrome) and Asian Indians. Curr Sci. 2002; 83:1483-96.
28. Chugh S, Dash RJ, Sialy R. Relationship of insulin resistance and hypertension and body habitus in north Indian subjects with a normal glucose tolerance. Indian J Nephrol. 1996; 6:153-61.
29. Mohan V, Shanthirani S, Deepa R, Premalatha G. Intraurban differences in the prevalence of the metabolic syndrome in southern India- the Chennai urban population. Diabetes Care. 1998; 21:967-71.
30. Nereida KC, Abbasi F, Lamendola C, Reaven GM; Prevalence of Insulin Resistance and Related Risk Factors for Cardiovascular Disease in Patients With Essential Hypertension, American Journal of Hypertension, Volume 22, Issue 1, 1 January 2009, Pp 106–111.
31. Salagre SB, Itolikar SM, Churiwaia JJ. Prevalence and clinical profile of metabolic syndrome in hypertensive subjects.Journal Association Physicians India. 2016; 64:22-4.
32. Alves LMM, Rigotti AR, Nogueira MS, Cesarino CB, Godoy SD. Metabolic syndrome components in arterial hypertension. Rev Esc Enferm USP. 2012; 46(6):1349-54.
33. Makwana D, Bagga S, NandalM;Prevalence of Metabolic Syndrome in Patients with Essential HypertensionIndian Journal of Clinical Practice, Vol. 24, No. 9, February 2014
34. Kanauchi M, Kanauchi K, Hashimoto T, et al. Metabolic syndrome and new category ‘pre-hypertension’ in a Japanese population. Curr Med Res Opin. 2004; 20:1365–1370.
35. Mohan G, Kaur R, Nayyar GS, Singh P. To study the prevalence of insulin resistance in non-diabetes hypertensive subjects.Int J Adv Med 2017;4: 92-7.